🇺🇸 FDA
Patent

US 8128939

Mutants of cholesterol-dependent cytolysins and uses thereof

granted A61KA61K38/00A61K39/00

Quick answer

US patent 8128939 (Mutants of cholesterol-dependent cytolysins and uses thereof) held by The Board of Regents of the University of Oklahoma expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/00, A61K39/00